NAVERIS INC.

In News

Test in Identification of Molecular Residual Disease of Anal Squamous Cell Carcinoma - Business Wire

Business Wire - Nov 17, 2025

Naveris® to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Business Wire - Jan 09, 2026

Naveris Announces Expanded Commercial Payor Coverage for NavDx® Test from Blue Shield of California - BioSpace

BioSpace - Oct 09, 2024

Breakthrough DNA Blood Test Detects Cancer Earlier to Help Patients Beat Head and Neck Cancer - The Medical University of South Carolina

The Medical University of South Carolina - Apr 29, 2022

Naveris awarded ADLT status by CMS for the NavDx test - Select Science

Select Science - Jun 11, 2024

Naveris Raises $51M for Early Detection of Viral-Driven Cancers - HIT Consultant

HIT Consultant - Sep 21, 2022

P-RAD Trial Shows Increased T-Cell Infiltration With Preoperative Radiation Added to Anti-PD-1 Therapy in Early Breast Cancer - The ASCO Post

The ASCO Post - Dec 11, 2025

Naveris raises $51 million in Series A financing - Health Tech World

Health Tech World - Sep 19, 2022

Preoperative radiation may enhance treatment response in patients with HR-positive, HER2-negative breast cancer - News-Medical

News-Medical - Dec 11, 2025

Naveris Announces Expansion of the NavDx® Test in Anal Cancer Molecular Residual Disease Surveillance - BioSpace

BioSpace - Jan 10, 2025

New Saliva Test Detects Head and Neck Cancer – Shows Promising Results - Onco'Zine

Onco'Zine - Jun 06, 2021

Naveris Introduces Advanced NavDx+Gyn™ Test for Early Detection of HPV-Driven Gynecologic Cancers - Business Wire

Business Wire - Mar 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment